[Table/Fig-1]:
Baseline characteristics.
| Interstitial Lung Disease | Chronic Obstructive Pulmonary Disease |
PostTB Sequelae | Overall | p-value | |||||
|---|---|---|---|---|---|---|---|---|---|
| Age (mean in years) | 43.57692 | 57.26923 | 53.3 | 51.22222 | 0.594 | ||||
| Sex | Males | Females | Males | Females | Males | Females | Males | Females | 0.028 |
| 33 | 36 | 28 | 11 | 21 | 10 | 82 | 57 | ||
| Height (mean, in cms) | 153.5 | 158.6923 | 160.35 | 157.2778 | 0.654 | ||||
| Weight (mean, in kgs) | 54.90385 | 56 | 53.45 | 54.89583 | 0.547 | ||||
| 6MWD (mean, in meters) | 324.5188 | 286.0146 | 357.385 | 319.744 | 0.789 | ||||
| FEV1 (mean, in litres) | 1.600769 | 1.246923 | 1.137 | 1.344167 | 0.1754 | ||||
| FEV1% predicted (mean) | 69.88462 | 60.65385 | 56.25 | 62.76389 | 0.610 | ||||
| FVC (mean, in litres) | 2.043846 | 1.897308 | 1.908 | 1.953194 | 0.003 | ||||
| FVC% predicted (mean) | 66.23077 | 72.88462 | 71.75 | 70.16667 | 0.008 | ||||
| FEV1/FVC (mean) | 79.07692 | 63.26923 | 60.7 | 68.26389 | 0.158 | ||||
From this table it can be observed that at the initiation of study there was no significant difference in age, height, weight, 6MWD, FEV1, among three groups as determined by One-Way ANOVA. Also as determined by Kruskal-Wallis test there was no difference in FEV% predicted, FEV1/FVC among three groups. However there was significant difference in gender (Chi square test), FVC and FVC% predicted among three groups.